13D Filing: Biotechnology Value Fund LP and BioLineRX Ltd. (BLRX)

Page 7 of 15

Page 7 of 15 – SEC Filing

1 NAME OF REPORTING PERSON
BVF INC.
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☒
(b) ☐
3 SEC USE ONLY
4 SOURCE OF FUNDS
AF
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
6 CITIZENSHIP OR PLACE OF ORGANIZATION
DELAWARE
NUMBER OF 7 SOLE VOTING POWER
SHARES
BENEFICIALLY – 0 –
OWNED BY 8 SHARED VOTING POWER
EACH
REPORTING 26,026,200*
PERSON WITH 9 SOLE DISPOSITIVE POWER
– 0 –
10 SHARED DISPOSITIVE POWER
26,026,200*
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
26,026,200*
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
24.99%
14 TYPE OF REPORTING PERSON
CO

____________________

* Represents 26,026,200 ADSs
(each ADS represents one Share (as defined below)). Includes 30,625 ADSs issuable upon the exercise of certain Series A
Warrants (as defined below).

7

Follow Biolinerx Ltd. (NASDAQ:BLRX)

Page 7 of 15